iHuman Statistics

Total Valuation

iHuman has a market cap or net worth of $83.74 million. The enterprise value is -$71.84 million.

Market Cap	83.74M
Enterprise Value	-71.84M

Important Dates

The last earnings date was Friday, June 28, 2024, before market open.

Earnings Date	Jun 28, 2024
Ex-Dividend Date	n/a

Share Statistics

iHuman has 51.06 million shares outstanding.

Shares Outstanding	51.06M
Owned by Insiders (%)	n/a
Owned by Institutions (%)	8.74%
Float	n/a

Valuation Ratios

The trailing PE ratio is 4.34 and the forward PE ratio is 58.14.

PE Ratio	4.34
Forward PE	58.14
PS Ratio	0.61
Forward PS	n/a
PB Ratio	0.69
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.00.

Current Ratio	2.67
Quick Ratio	2.45
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 16.40% and return on invested capital (ROIC) is 12.21%.

Return on Equity (ROE)	16.40%
Return on Assets (ROA)	10.70%
Return on Capital (ROIC)	12.21%
Revenue Per Employee	$175,241
Profits Per Employee	$26,530
Employee Count	783
Asset Turnover	0.71
Inventory Turnover	17.69

Taxes

In the past 12 months, iHuman has paid $2.30 million in taxes.

Income Tax	2.30M
Effective Tax Rate	9.97%

Stock Price Statistics

The stock price has decreased by -44.78% in the last 52 weeks. The beta is 0.39, so iHuman's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	-44.78%
50-Day Moving Average	1.85
200-Day Moving Average	2.22
Relative Strength Index (RSI)	41.54
Average Volume (20 Days)	28,153

Short Selling Information

Short Interest	9,622
Short Previous Month	5,082
Short % of Shares Out	0.02%
Short % of Float	n/a
Short Ratio (days to cover)	0.42

Income Statement

In the last 12 months, iHuman had revenue of $137.21 million and earned $20.77 million in profits. Earnings per share was $0.38.

Revenue	137.21M
Gross Profit	97.07M
Operating Income	16.64M
Pretax Income	22.93M
Net Income	20.77M
EBITDA	n/a
EBIT	22.93M
Earnings Per Share (EPS)	$0.38

Full Income Statement

Balance Sheet

The company has $156.04 million in cash and $457,630 in debt, giving a net cash position of $155.58 million or $3.05 per share.

Cash & Cash Equivalents	156.04M
Total Debt	457,630
Net Cash	155.58M
Net Cash Per Share	$3.05
Equity (Book Value)	122.14M
Book Value Per Share	2.39
Working Capital	113.32M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 70.75%, with operating and profit margins of 12.13% and 15.14%.

Gross Margin	70.75%
Operating Margin	12.13%
Pretax Margin	16.71%
Profit Margin	15.14%
EBITDA Margin	n/a
EBIT Margin	16.71%
FCF Margin	n/a

Dividends & Yields

iHuman does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.76%
Shareholder Yield	0.76%
Earnings Yield	24.81%
FCF Yield	n/a

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

iHuman has an Altman Z-Score of 2.45 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.45
Piotroski F-Score	6